Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis-Reference-Cited by-同舟云学术

Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis

Published:2016-07 Issue:1 Volume:75 Page:83-98.e4
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

van de Kerkhof Peter C.M.,Griffiths Christopher E.M.,Reich Kristian,Leonardi Craig L.,Blauvelt Andrew,Tsai Tsen-Fang,Gong Yankun,Huang Jiaqing,Papavassilis Charis,Fox Todd

Publisher

Elsevier BV

Subject

Dermatology

Reference58 articles.

1. Psoriasis;Nestle;N Engl J Med,2009

2. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics;Menter;J Am Acad Dermatol,2008

3. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions;Menter;J Am Acad Dermatol,2011

4. Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting;Gelfand;Arch Dermatol,2012

5. Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis;Hueber;Sci Transl Med,2010

Cited by 275 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shared Pathophysiology of Inflammatory Bowel Disease and Psoriasis: Unraveling the Connection;Cureus;2024-09-03

2. Review of dermatologic drugs relevant to inflammatory bowel disease;JAAD Reviews;2024-09

3. The Impact of Psoriasis Treatments on the Risk of Skin Cancer: A Narrative Review;Advances in Therapy;2024-08-28

4. The management of axial spondyloarthritis with cutting-edge therapies: advancements and innovations;Expert Opinion on Biological Therapy;2024-08-02

5. Psoriasis and psoriatic arthritis following use of dostarlimab for endometrial cancer;BMJ Case Reports;2024-08